Search
RBIO-101
go.drugbank.com/drugs/DB18425ExperimentalRBIO-101 is a recombinant adeno-associated virus vector encoding human CYP4V2 protein.
Vurolenatide
go.drugbank.com/drugs/DB18440InvestigationalVurolenatide is a recombinant fusion protein comprising exenatide and XTEN.
UV1
go.drugbank.com/drugs/DB18470ExperimentalUV1 is a cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit
Emerfetamab
go.drugbank.com/drugs/DB18474InvestigationalEmerfetamab is a bispecific T cell engager antibody construct with a half-life extension Fc moiety capable of binding to the neonatal Fc receptor.
ISB 1442
go.drugbank.com/drugs/DB18475InvestigationalISB 1442 is a bispecific, biparatopic antibody targeting CD38 and CD47
BCX10013
go.drugbank.com/drugs/DB18496InvestigationalBCX10013 is a small molecule inhibitor of human complement factor D.
BBP-671
go.drugbank.com/drugs/DB18498InvestigationalBBP-671 is a small molecule activator of pantothenate kinases.
MDR-101
go.drugbank.com/drugs/DB18513InvestigationalMDR-101 is a CD34+ hematopoietic stem and progenitor cells with CD3+ T-cells
DSP-5336
go.drugbank.com/drugs/DB18514InvestigationalDSP-5336 is a menin inhibitor.
Synonyms: BENZAMIDE, 5-FLUORO-2-((4-(7-(((1S,3S,4R)-5-METHYLENE-2-AZABICYCLO(2.2.2)OCT-3-YL)CARBONYL)-2,7-DIAZASPIRO(3.5)NON-2-YL)-5-PYRIMIDINYL)OXY)-N,N-BIS(1-METHYLETHYL)-Lusacomfar Alfa
go.drugbank.com/drugs/DB18526ExperimentalLusacomfar Alfa is a recombinant complement factor H